1642P The role of BRAF/MEKi rechallenge in BRAFV600 mutated melanoma patients: Insights from a EUMelaReg real-world study. - Gavrilova, I.; Weichenthal, M.; Asher, N.; Ulrich, J.; Ellebaek, E.; Kreuter, A.; Popovic, A.; Stojkovski, I.; Levari, S.; Özdemir, B.; García Castaño, A.; Haanen, J.B.A.G.; et al. (Annals of Oncology, 2025)